Tuesday, February 03, 2026 | 08:09 AM ISTहिंदी में पढें
Kwality Pharmaceuticals Ltd
Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On 31St December 2025.
02:26 PM, 2nd Feb 2026
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on 31st December 2025.